The Press and Journal (Inverness, Highlands, and Islands)

High cost of drugs hammering NHS Grampian budget

- KIRSTIE TOPP

NHS Grampian finance chiefs say soaring drug costs are contributi­ng to a cash crisis. A paper explaining the body’s finances went before members of the board yesterday, with grim warnings about the year ahead.

Even though chiefs managed to balance the books in the last financial year, they have admitted that major challenges lie ahead.

It has been estimated that the health board faces a £60 million black hole over the next year.

Assistant director of finance Alan Sharp yesterday explained that multiple factors were to blame.

But he noted that inflationa­ry pressures were a “significan­t” contributo­r, particular­ly costs for energy, drugs and medical supplies.

Mr Sharp also told board members that a number of one-off measures used to help balance the books last year will not be available again.

The increasing cost of drugs raised some worries with board members.

Dennis Robertson asked if any work was going on with drug companies to find a way to reduce prices.

Mr Sharp told him that conversati­ons about drug costs were ongoing at both a UK and Scotland level, after rumours of a two-tier system for prescripti­ons made headlines last year.

He said: “There is a national UK-wide scheme which regulates the costs of some very high-cost hospital drugs.

“That’s currently being reviewed by the Westminste­r government who are in negotiatio­ns with the pharmaceut­ical companies.”

He added: “There are also big pressures on

costs around the drugs which GPs prescribe at the moment and they particular­ly impact on our health and social care partnershi­ps.

“A lot of that is just down to inflationa­ry pressures of the cost of raw materials and labour, which has gone up across the world and not helped by the conflict in Ukraine.

“There are discussion­s ongoing, but there’s still a lot of upward pressure on our drug costs at the moment.”

How much do prescripti­ons cost NHS Grampian?

The latest figures, from February 2023, show that north-east GPs prescribed 806,883 items at a cost of nearly £10.2m that month alone.

Omeprazole tops the

table as the most common drug issued to patients.

It is used to treat heartburn and indigestio­n.

Paracetamo­l was the second most prescribed medication.

NHS Grampian’s most prescribed medication­s and their total costs in February 2023:

Omeprazole (29,516) – £157,365

Paracetamo­l (14,368) – £53,018

Aspirin (10,912) – £17,890

Salbutamol inhaler (10,474) – £19,466

Amlodipine (9,652) – £12,512

Atorvastat­in (8,820) – £14,862

Levothyrox (8,724) – £15,713

Ramipril (8,348) – £17,737

Amoxicilli­n (8,077) – £28,925

Sertraline (7,271) – £11,745

Chief executive of NHS Grampian Professor Caroline Hiscox said the financial position was an “absolutely critical” part of its decision-making.

She added: “That requires us to think about the longer term and to be really clear and transparen­t about why and how we are making our decisions,” she explained.

It comes after Scottish Government funding in March helped relieve some pressure, along with staff using up annual leave carried on from the previous year.

NHS Grampian will work closely with integratio­n joint boards and local councils in a bid to try to find potential savings.

 ?? ?? DECISIONS: Chief executive of NHS Grampian Professor Caroline Hiscox.
DECISIONS: Chief executive of NHS Grampian Professor Caroline Hiscox.

Newspapers in English

Newspapers from United Kingdom